James Tetrud, MD, a movement disorder specialist at Stanford, will be talking about medications for treating PD motor symptoms at the Palo Alto Parkinson’s Support Group meeting on Wednesday, April 12th, 2-3:30pm.
In terms of medications, he will be addressing what’s old, what’s new, and what’s in the pipeline. The meeting is held at Avenidas, 450 Bryant Street, Palo Alto. This event is free and open to the community. No RSVP is required.
Dr. Tetrud is well-known in the local Parkinson’s community and the worldwide research community. In the early 1980s, he co-authored a report on the discovery of MPTP-induced parkinsonism in IV drug users. He joined Dr. Bill Langston in establishing The Parkinson’s Institute in 1988 and was the Medical Director for over 25 years. His focus has been the medical management of Parkinson’s disease and other movement disorders. He has been the principal investigator on numerous clinical drug trials, primarily in patients with Parkinson’s disease, and has special interest in quantification of motor function.